← Отчётные звонки
FSLR FY2026 Q1 Улучшается

Отчётный звонок First Solar, Inc.

Apr 30, 2026 · 16:30 ET Alex BradleyFirst Solar Investor RelationsMark Widmar earningscall_biz
Вывод Buzzberg

CURE launch complete; rollout through 2028 could add $0.6B revenue.

First Solar reported a record Q1 with strong margins and EBITDA, but the key signals were about the policy-dependent future of its US and international capacity. Management reiterated its selective booking strategy, waiting on the Section 232 decision to unlock demand and potentially re-engage its Southeast Asian capacity. The competitive landscape is being shaped by IP enforcement against TopCon and the ramp of its new CURE technology. Record Q1 revenue of $1B and adjusted EBITDA of $520M, exceeding guidance.

Вывод Buzzberg CURE launch complete; rollout through 2028 could add $0.6B revenue. First Solar reported a record Q1 with strong margins and EBITDA, but the key signals were about the policy-dependent future of its US and international capacity. Management reiterated its selective booking strategy, waiting on the Section 232 decision to unlock demand and potentially re-engage its Southeast Asian capacity. The competitive landscape is being shaped by IP enforcement against TopCon and the ramp of its new CURE technology. Record Q1 revenue of $1B and adjusted EBITDA of $520M, exceeding guidance. Читать полный анализСвернуть анализ

First Solar reported a record Q1 with strong margins and EBITDA, but the key signals were about the policy-dependent future of its US and international capacity. Management reiterated its selective booking strategy, waiting on the Section 232 decision to unlock demand and potentially re-engage its Southeast Asian capacity. The competitive landscape is being shaped by IP enforcement against TopCon and the ramp of its new CURE technology. Record Q1 revenue of $1B and adjusted EBITDA of $520M, exceeding guidance.

  • Gross bookings of 1.7GW, with US bookings at ~$0.34/W ASP, maintaining discipline.
  • Management reaffirmed FY2026 guidance, expecting stronger H2 margins.
  • CURE technology launch complete, aiming for 8% energy yield advantage; pricing shifts to base ASPs, reducing adders.
Выручка$1.0442B-38% к/к
EPS$3.22-33% к/к
Валовая маржа46.55%Факт
Операционная маржа33.07%Факт
6 подтверждённых тезисов

Что важно сейчас

Самые значимые изменения по итогам звонка.

01
Technology

CURE launch complete; rollout through 2028 could add $0.6B revenue.

02
Demand

Strong U.S. bookings at 35 cents per watt.

03
Demand

North American production largely committed through 2028.

Показать ещё 3 тезиса
04
Regulatory

Trade IP investigation set to proceed with initial determination within 11 months.

05
R&D

Perovskite pilot line planned for 2027.

06
Guidance

Tariff assumptions may change if 232 decision alters policy.

Отчётный период

Фактические результаты

ПоказательФактИзменение
Выручка$1.0442B-38% к/к
EPS$3.22-33% к/к
Валовая маржа46.55%Факт
Операционная маржа33.07%Факт
Свободный денежный поток$-0.3334BФакт
Капзатраты$0.1185BФакт
Прогнозные данные

Прогноз компании

ПоказательПериодДиапазонСерединаСтатус
Свободный денежный потокFY2026 Q2$400–$500$450Подтверждён
ОбъёмFY2026 Q23.4–43.7Подтверждён
AI, капзатраты и спрос

Оценка менеджмента

Тон

Measured

Management expressed confidence in strategic positioning and technology advantages, but remained cautious regarding pending policy and tariff decisions, emphasizing selective booking and disciplined approach.

Капзатраты

Инвестиции и мощности

Management outlined capacity investments including the South Carolina finishing facility and a perovskite pilot line, with capital expenditures of $119 million in Q1, primarily for the South Carolina facility. They expect the South Carolina facility to start production in the second half of 2026.

все упомянутые компании ниже: 1

Компаниис момента звонка

Конкуренты

Конкуренты

If Tesla adopts TopCon for its US manufacturing, it may infringe on First Solar's IP, potentially leading to licensing negotiations or legal action.

Доказательства
“I do think it's one of the challenges that you know, tesla's going to have to figure out what what technology they go with and how do they get freedom to operate”
Mark Widmar
Внешние сигналы

Альфа цепочки поставок · 3с момента звонка

A1

First Solar holds ~1.8-2GW of fully-finished module capacity in Malaysia/Vietnam that is tethered to the 232 tariff decision.

Доказательства
“There's only about, call it 1.8 gigawatts, maybe closer to two of real capacity. So what we're talking about is from a full-size finishing module capacity perspective.”
A2

First Solar is pricing its new CURE technology into base ASPs, reducing the prevalence of technology adjusters in new contracts.

Доказательства
“For the windows of which we for sure are going to be delivering the cure product, we'll just price it as the contract. And you won't necessarily continue to see the adders.”
A3

India module demand is strong, with ASPs at ~$0.20/watt, but Q3 demand softens.

Доказательства
“Q3, we see a little bit of softness generally in India, and then you'll see a stronger Q4.”
Методология и полнота

Анализ основан только на заявлениях менеджмента. Показаны все подтверждённые упоминания компаний: 1. Фактические результаты и прогнозы разделены. Публичные доказательства ограничены восемью короткими атрибутированными цитатами. AI-анализ может быть неполным или ошибочным — проверяйте важные утверждения по первоисточнику.